Skip to main content
57°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Joseph Tucker
Recent news which mentions Joseph Tucker
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
November 25, 2024
Tickers
ENVB
NEWS
Tags
Benzinga
premium
News
From
Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
Tickers
ENVB
NEWS
Tags
Cannabis
Joseph Tucker
Market News
From
Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
Tickers
ENVB
NEWS
Tags
Benzinga
News
ENVB
From
Benzinga
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
October 15, 2024
Tickers
ENVB
NEWS
Tags
Psychedelic Assisted Therapies
Benzinga
Psychedelics
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Enveric Biosciences
Psychedelics
Top Stories
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
Tickers
CCC
ENVB
NEWS
Tags
ENVB
News
Health Care
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Tickers
DMT
ENVB
NEWS
Tags
ENVB
DMT
Psychedelics
From
Benzinga
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
July 11, 2024
Tickers
ENVB
Tags
Market News
Joseph Tucker
Cannabis
From
Benzinga
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
May 16, 2024
Tickers
ENVB
NEWS
Tags
Earnings
psychedelics addiction
EB/003
From
Benzinga
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
Justin Hanka
Cannabis
Markets
From
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Tickers
ENVB
NEWS
Tags
Cannabis
Joseph Tucker
Market News
From
Benzinga
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
August 21, 2023
Tickers
ENVB
Tags
Market News
Joseph Tucker
Cannabis
From
Benzinga
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
July 24, 2023
Tickers
ENVB
Tags
News
Penny Stocks
ENVB
From
Benzinga
Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety
July 17, 2023
Tickers
ENVB
Tags
ENVB
Psychedelics
News
From
Benzinga
Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
June 26, 2023
Tickers
ENVB
Tags
premium
Benzinga
ENVB
From
Benzinga
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
June 05, 2023
Tickers
ENVB
Tags
Why is it moving?
Market News
Joseph Tucker
From
Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
May 24, 2023
Tickers
ENVB
Tags
Penny Stocks
News
Psychedelics
From
Benzinga
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
May 22, 2023
Tickers
ENVB
Tags
ENVB
Psychedelics
News
From
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Tickers
ENVB
Tags
Benzinga
premium
News
From
Benzinga
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Tickers
ENVB
Tags
Akos Biosciences
Enveric Biosciences
Benzinga
From
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Tickers
ENVB
PSYBF
TRYPF
Tags
Anne Donohoe
Small Cap
Market News
From
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
Tickers
CBD
ENVB
Tags
Market News
Joseph Tucker
Biotech
From
Benzinga
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
Tickers
ENVB
TGODF
TLRY
Tags
ENVB
News
Penny Stocks
From
Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
September 17, 2021
Tickers
ENVB
Tags
Benzinga
MagicMed
Penny Stocks
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.